| Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products. The Company is very pleased to report the continuing successful progress by patient who has been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer. Cannabis Science is in a unique position to evaluate the effectiveness of different formulations by working closely with physicians and patients in medical marijuana states where patient...continued CBIS |
Tuesday, January 3, 2012
More Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed As Self Medicating Squamous Cell Carcinoma Patient Reports Continued Shrinking of Cancer Tumor
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment